Overview
DuoNeb is a prescription drug approved by the Food and Drug Administration (FDA) to treat bronchospasm in people with chronic obstructive pulmonary disease (COPD) who need more than one bronchodilator. DuoNeb is a combination drug composed of Ipratropium and Albuterol.

Both Ipratropium and Albuterol are short-acting bronchodilators, or drugs that dilate the bronchi and bronchioles in the lungs. Ipratropium is an anticholinergic, while Albuterol is a beta2-adrenergic agonist. Both drugs are believed to work by relaxing and dilating the airways, making it easier to breathe.

How do I take it?
DuoNeb is taken four to six times a day by nebulizer.

DuoNeb come... read more

DuoNeb (Ipratropium/Albuterol) Questions

MyCOPDTeam is a free social network that makes it easy to find others like you and gain insights from others living with COPD.
Sign up Log in